DaShenLin Pharmaceutical Group Co (SHSE:603233) Accounts Payable & Accrued Expense : ¥9,671 Mil (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is DaShenLin Pharmaceutical Group Co Accounts Payable & Accrued Expense?

DaShenLin Pharmaceutical Group Co's quarterly accounts payable & accrued expense increased from Sep. 2023 (¥7,655 Mil) to Dec. 2023 (¥9,284 Mil) and increased from Dec. 2023 (¥9,284 Mil) to Mar. 2024 (¥9,671 Mil).

DaShenLin Pharmaceutical Group Co's annual accounts payable & accrued expense increased from Dec. 2021 (¥5,923 Mil) to Dec. 2022 (¥7,564 Mil) and increased from Dec. 2022 (¥7,564 Mil) to Dec. 2023 (¥9,284 Mil).

DaShenLin Pharmaceutical Group Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for DaShenLin Pharmaceutical Group Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DaShenLin Pharmaceutical Group Co Accounts Payable & Accrued Expense Chart

DaShenLin Pharmaceutical Group Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

3,889.09

5,202.71

5,922.74

7,564.46

9,284.15

DaShenLin Pharmaceutical Group Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															7,261.09	7,120.86	7,654.71	9,284.15	9,671.50

DaShenLin Pharmaceutical Group Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

DaShenLin Pharmaceutical Group Co (SHSE:603233) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DaShenLin Pharmaceutical Group Co Ltd (SHSE:603233) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 410-1, Longxi Avenue, Liwan District, Guangdong Province, Guangzhou, CHN, 510000

Website

http://www.dslyy.com

DaShenLin Pharmaceutical Group Co Ltd is engaged in the pharmaceutical manufacturing, retail and wholesale business. The company is based on the development of the pharmacy chain. It primarily offers Chinese herbal medicine such as antibiotics and biochemical drugs. The business activities are geographically carried out through China.

DaShenLin Pharmaceutical Group Co (SHSE:603233) Headlines

No Headlines